201 related articles for article (PubMed ID: 31908034)
1. Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption.
Inoue K; Hu X; Zhao B
FASEB J; 2020 Feb; 34(2):2392-2407. PubMed ID: 31908034
[TBL] [Abstract][Full Text] [Related]
2. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
[TBL] [Abstract][Full Text] [Related]
3. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.
Zhao B; Grimes SN; Li S; Hu X; Ivashkiv LB
J Exp Med; 2012 Feb; 209(2):319-34. PubMed ID: 22249448
[TBL] [Abstract][Full Text] [Related]
4. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.
Li S; Miller CH; Giannopoulou E; Hu X; Ivashkiv LB; Zhao B
J Clin Invest; 2014 Nov; 124(11):5057-73. PubMed ID: 25329696
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption.
Zhao B
Front Endocrinol (Lausanne); 2020; 11():583561. PubMed ID: 33133025
[TBL] [Abstract][Full Text] [Related]
6. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.
Binder N; Miller C; Yoshida M; Inoue K; Nakano S; Hu X; Ivashkiv LB; Schett G; Pernis A; Goldring SR; Ross FP; Zhao B
J Immunol; 2017 May; 198(9):3436-3447. PubMed ID: 28314855
[TBL] [Abstract][Full Text] [Related]
7. MIP-1δ activates NFATc1 and enhances osteoclastogenesis: involvement of both PLCγ2 and NFκB signaling.
Weber KL; Doucet M; Shaner A; Hsu N; Huang D; Fogel J; Kominsky SL
PLoS One; 2012; 7(7):e40799. PubMed ID: 22792407
[TBL] [Abstract][Full Text] [Related]
8. Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways.
Wu Z; Wu H; Li C; Fu F; Ding J; Shao S; Li K; Yu X; Su Y; Liang J; Lin X; Yuan G; Zhou J; Song F; Zhao J; Xu J; Liu Q; Xu F
J Cell Physiol; 2019 Aug; 234(10):17812-17823. PubMed ID: 30815894
[TBL] [Abstract][Full Text] [Related]
9. A mutation of cysteine 46 in IKK-β promotes mPGES-1 and caveolin-1 expression to exacerbate osteoclast differentiation and osteolysis.
Zou B; Zhang Y; Li T; Liu J; Deng W; Tan Y; Yang Q; Ding Z; Liao K; Xu J; Pan H; Li X; Liu L
Biochem Pharmacol; 2020 Feb; 172():113762. PubMed ID: 31843541
[TBL] [Abstract][Full Text] [Related]
10. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
11. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
Doi K; Murata K; Ito S; Suzuki A; Terao C; Ishie S; Umemoto A; Murotani Y; Nishitani K; Yoshitomi H; Fujii T; Watanabe R; Hashimoto M; Murakami K; Tanaka M; Ito H; Park-Min KH; Ivashkiv LB; Morinobu A; Matsuda S
Arthritis Rheumatol; 2022 Jun; 74(6):948-960. PubMed ID: 35077015
[TBL] [Abstract][Full Text] [Related]
12. Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells.
Blüml S; Friedrich M; Lohmeyer T; Sahin E; Saferding V; Brunner J; Puchner A; Mandl P; Niederreiter B; Smolen JS; Schabbauer G; Redlich K
Ann Rheum Dis; 2015 Jan; 74(1):227-33. PubMed ID: 24078675
[TBL] [Abstract][Full Text] [Related]
13. Jagged1 Acts as an RBP-J Target and Feedback Suppresses TNF-Mediated Inflammatory Osteoclastogenesis.
Ng C; Qin Y; Xia Y; Hu X; Zhao B
J Immunol; 2023 Nov; 211(9):1340-1347. PubMed ID: 37756541
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.
Lee MJ; Lim E; Mun S; Bae S; Murata K; Ivashkiv LB; Park-Min KH
J Cell Physiol; 2016 Feb; 231(2):449-458. PubMed ID: 26189496
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the transcription factor RBP-J results in osteopenia attributable to attenuated osteoclast differentiation.
Ma J; Liu YL; Hu YY; Wei YN; Zhao XC; Dong GY; Qin HY; Ding Y; Han H
Mol Biol Rep; 2013 Mar; 40(3):2097-105. PubMed ID: 23224519
[TBL] [Abstract][Full Text] [Related]
16. The tethering function of mitofusin2 controls osteoclast differentiation by modulating the Ca
Ballard A; Zeng R; Zarei A; Shao C; Cox L; Yan H; Franco A; Dorn GW; Faccio R; Veis DJ
J Biol Chem; 2020 May; 295(19):6629-6640. PubMed ID: 32165499
[TBL] [Abstract][Full Text] [Related]
17. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Peroxisome Proliferator-Activated Receptor γ Coactivator 1β/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid Arthritis.
Ma JD; Jing J; Wang JW; Mo YQ; Li QH; Lin JZ; Chen LF; Shao L; Miossec P; Dai L
Arthritis Rheumatol; 2019 Aug; 71(8):1252-1264. PubMed ID: 30802366
[TBL] [Abstract][Full Text] [Related]
19. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.
Zheng H; Liu Y; Deng Y; Li Y; Liu S; Yang Y; Qiu Y; Li B; Sheng W; Liu J; Peng C; Wang W; Yu H
Mol Med; 2024 Feb; 30(1):20. PubMed ID: 38310228
[TBL] [Abstract][Full Text] [Related]
20. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
